119 related articles for article (PubMed ID: 18233118)
1. Quantifying intrinsic specificity: a potential complement to affinity in drug screening.
Wang J; Zheng X; Yang Y; Drueckhammer D; Yang W; Verkhivker G; Wang E
Phys Rev Lett; 2007 Nov; 99(19):198101. PubMed ID: 18233118
[TBL] [Abstract][Full Text] [Related]
2. Structure-based parallel medicinal chemistry approach to improve metabolic stability of benzopyran COX-2 inhibitors.
Xing L; Hamper BC; Fletcher TR; Wendling JM; Carter J; Gierse JK; Liao S
Bioorg Med Chem Lett; 2011 Feb; 21(3):993-6. PubMed ID: 21215625
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new ibuprofen derivatives with their in silico and in vitro cyclooxygenase-2 inhibitions.
Gundogdu-Hizliates C; Alyuruk H; Gocmenturk M; Ergun Y; Cavas L
Bioorg Chem; 2014 Feb; 52():8-15. PubMed ID: 24270352
[TBL] [Abstract][Full Text] [Related]
4. The study of dual COX-2/5-LOX inhibitors by using electronic-topological approach based on data on the ligand-receptor interactions.
Aksakal F; Shvets N; Dimoglo A
J Mol Graph Model; 2015 Jul; 60():79-88. PubMed ID: 26117823
[TBL] [Abstract][Full Text] [Related]
5. Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs.
Bommu UD; Konidala KK; Pamanji R; Yeguvapalli S
Interdiscip Sci; 2019 Jun; 11(2):153-169. PubMed ID: 29236213
[TBL] [Abstract][Full Text] [Related]
6. Binding energy landscape analysis helps to discriminate true hits from high-scoring decoys in virtual screening.
Wei D; Zheng H; Su N; Deng M; Lai L
J Chem Inf Model; 2010 Oct; 50(10):1855-64. PubMed ID: 20968314
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R
Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking studies of novel palmitoyl-ligands for cyclooxygenase-2.
Bhagavat R; Saqib A; Karigar C
Chem Biol Drug Des; 2012 Jun; 79(6):1043-8. PubMed ID: 22339889
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
10. Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors.
Franke L; Byvatov E; Werz O; Steinhilber D; Schneider P; Schneider G
J Med Chem; 2005 Nov; 48(22):6997-7004. PubMed ID: 16250658
[TBL] [Abstract][Full Text] [Related]
11. Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent.
Somvanshi RK; Kumar A; Kant S; Gupta D; Singh SB; Das U; Srinivasan A; Singh TP; Dey S
Biochem Biophys Res Commun; 2007 Sep; 361(1):37-42. PubMed ID: 17640617
[TBL] [Abstract][Full Text] [Related]
12. Novel 1-[4-(Aminosulfonyl)phenyl]-1H-1,2,4-triazole derivatives with remarkable selective COX-2 inhibition: design, synthesis, molecular docking, anti-inflammatory and ulcerogenicity studies.
Abuo-Rahma Gel-D; Abdel-Aziz M; Farag NA; Kaoud TS
Eur J Med Chem; 2014 Aug; 83():398-408. PubMed ID: 24983538
[TBL] [Abstract][Full Text] [Related]
13. A simple QM/MM approach for capturing polarization effects in protein-ligand binding free energy calculations.
Beierlein FR; Michel J; Essex JW
J Phys Chem B; 2011 May; 115(17):4911-26. PubMed ID: 21476567
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking studies of withanolides against Cox-2 enzyme.
Prabhakaran Y; Dinakaran SK; Macharala SP; Ghosh S; Karanam SR; Kanthasamy N; Avasarala H
Pak J Pharm Sci; 2012 Jul; 25(3):595-8. PubMed ID: 22713947
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors.
Khanna S; Madan M; Vangoori A; Banerjee R; Thaimattam R; Jafar Sadik Basha SK; Ramesh M; Casturi SR; Pal M
Bioorg Med Chem; 2006 Jul; 14(14):4820-33. PubMed ID: 16581252
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
Ghodsi R; Zarghi A; Daraei B; Hedayati M
Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161
[TBL] [Abstract][Full Text] [Related]
17. Interactions of selected indole derivatives with COX-2 and their in silico structure modifications towards the development of novel NSAIDs.
Dileep KV; Remya C; Tintu I; Sadasivan C
J Biomol Struct Dyn; 2014; 32(11):1855-63. PubMed ID: 24053423
[TBL] [Abstract][Full Text] [Related]
18. Structural and Electronic Factors Influencing the Selective Inhibition of COX-2.
Aksakal F; Shvets N; Khairullina V; Dimoglo A
Mini Rev Med Chem; 2016; 16(7):579-94. PubMed ID: 26471968
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel 2-phenyl-5-(1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity.
Bansal S; Bala M; Suthar SK; Choudhary S; Bhattacharya S; Bhardwaj V; Singla S; Joseph A
Eur J Med Chem; 2014 Jun; 80():167-74. PubMed ID: 24780593
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
